The ‘conseller’ of Health, Joseph Maria Argimon, explained that the new Protocol for the care of women requesting a voluntary termination of pregnancy (ive) in Catalonia extends medical abortion to 14 weeks, that until now could be practiced up to nine weeks.

    He said it during the inauguration of the first working day of voluntary termination of pregnancy in Catalonia aimed at health professionals on the occasion of the International Day for the Decriminalization of Abortion that was held at the Vall d’Hebron Hospital in Barcelona.

    The ‘consellera’ of Igualtat i Feminismes, Tania Verge, has argued that abortion is a health issue but also a “autonomy and fundamental rights of women” and has defended that the new protocol is a recognition of a historical feminist vindication, has said.

    Argimon has specified that the ive by the pharmacological method se will offer in hospitals and highlighted that the new protocol also includes analgesic regimen recommendations, new procedure recommendations to be minimally invasive and reduce risks, as well as guidelines to treat comorbidities, among others.

    The head of Health has recognized that they have to increase the accessibility of this right although it has claimed that they have expanded the network for the practice of surgical abortions in Lleida, Berga, Manresa (Barcelona) and Tortosa (Tarragona) and that of pharmacological abortions in Tremp, Vielha (Lleida) and Puigcerdà (Girona).

    Argimon has ensured that, compared to the rest of Spain, the accessibility of abortion in Catalonia is “much higher” through the public and private resources of the Catalan health system and has stated verbatim that Spain is a desert in terms of the provision of this right if only public resources are analysed.

    Advantages of pharmacological ive

    The pharmacological ive “mimics the natural process of abortion”; it is less invasive; it can be done at home accompanied by family members; bleeding and expulsion can be programmed and predicted; and avoids the surgical procedure, general anesthesia and has less risk of complications.

    It’s an intervention “especially beneficial” for those women with obesity, uterine malformations, cervical surgery prior or who want to avoid surgery, explained the Clinical Coordinator of the sexual and reproductive health care unit in Mollet (Barcelona) and member of the Board of Directors of the Catalan Society of Gynecology and Obstetrics, Anna Torrent.

    Related news

    Likewise, Torrent has warned that the pharmacological ive requires more time to complete the treatment; may involve abdominal pain and bleeding; side effects such as nausea, diarrhea, vomiting and fever, among others; Y 5% of women require a second intervention.

    He clarified that the new protocol offers the possibility for women to choose the option of pharmacological IV up to week 14 of gestation: “The decision is always made by the woman, properly informed and accompanied by the health professional,” she claimed.